TP53 and glioblastoma: Altogether, the accumulation of M237I-p53 (Figure 2) species in glioblastoma cells and the presence of amyloid p53 oligomers (Figures 1, S2, and S4) potentially link oligomeric p53 mutant compositions to chemoresistance gain-of-function activity in glioblastoma.